CodaLytic™, a novel codon-pair deoptimized influenza virus creates an immune-stimulatory tumor microenvironment leading to monotherapy efficacy in a preclinical model of breast cancer

CodaLytic - Codagenix

https://jitc.bmj.com//content/9/Suppl_2/A778

Marcin Stawowczyk ; Katie Pfeffer ; Juliana Tafrova ; Charles Stauft ; Anna Kushnir ; Sybil Tasker ; Steffen Mueller ; J Robert Coleman ; Johanna Kaufmann

Oct 1, 2021